We serve Chemical Name:2-Fluoro-6-(trifluoromethyl)benzaldehyde CAS:60611-24-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Fluoro-6-(trifluoromethyl)benzaldehyde
CAS.NO:60611-24-7
Synonyms:α,α,α,6-Tetrafluoro-o-tolualdehyde;MFCD00061273;2263481;Benzaldehyde, 2-fluoro-6-(trifluoromethyl)-;VHR BF FXFFF;2-Fluoro-6-(trifluoromethyl)benzaldehyde;2-Fluor-6-trifluormethylbenzaldehyd
Molecular Formula:C8H4F4O
Molecular Weight:192.110
HS Code:2913000090
Physical and Chemical Properties:
Melting point:155-157°C
Boiling point:189.4±40.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.459
PSA:17.07000
Exact Mass:192.019821
LogP:2.60
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like α,α,α,6-Tetrafluoro-o-tolualdehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Fluor-6-trifluormethylbenzaldehyd physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,VHR BF FXFFF Use and application,2-Fluor-6-trifluormethylbenzaldehyd technical grade,usp/ep/jp grade.
Related News: Singapore, Australia, New Zealand, and the United States have banned all foreign nationals traveling from China from entering the country. 2-Fluoro-6-(trifluoromethyl)benzaldehyde manufacturer There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. 2-Fluoro-6-(trifluoromethyl)benzaldehyde supplier Singapore, Australia, New Zealand, and the United States have banned all foreign nationals traveling from China from entering the country. 2-Fluoro-6-(trifluoromethyl)benzaldehyde vendor There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 2-Fluoro-6-(trifluoromethyl)benzaldehyde factory The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.
